POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS

• 收藏
• 分享

专利权人:

DANA-FARBER CANCER INSTITUTE; INC.

发明人:

DANDREA, ALAN D.,CECCALDI, RAPHAEL

申请号：

CA3002541

公开号：

CA3002541A1

申请日:

2016.10.19

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The disclosure relates, in some aspects, to methods of treating homologous recombination (HR)-deficient cancers. In some embodiments, the disclosure provides method for treating HR-deficient cancer by administering a polymerase Q (PolQ) inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/